Headache News and Research

Latest Headache News and Research

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

Researchers evaluated the incidence of long coronavirus disease (long COVID) in a demographically diverse population with different disease severities to inform clinicians and future vaccine development strategies.

21 Jul 2022

New Oxford study examines the effectiveness of pharmacological treatments for insomnia

Two drugs, eszopiclone and lemborexant - both not currently licenced for the treatment of insomnia in the UK - were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia.

19 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

COVID-19 risks may be heightened by history of Lyme disease

Individuals with a history of Lyme disease, caused by tick bites are at a higher risk of severe COVID-19.

17 Jul 2022

CDC posts investigation notice about multistate outbreak of Listeria infections

A CDC Investigation Notice regarding a multistate outbreak of Listeria infections has been posted: Listeria Outbreak | CDC.Listeria Outbreak | CDC

10 Jul 2022

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.

8 Jul 2022

Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

Researchers compared the immunogenicity and safety of the protein-based heterodimer vaccine (PHH-1V) and BNT162b2 COVID-19 vaccines.

8 Jul 2022

What is the monkeypox transmission risk in metropolitan areas?

A new study discusses the possible patterns of spread of monkeypox, and strategies to contain such transmission.

7 Jul 2022

Neuropsychiatric symptoms prevalent in over 50% of monkeypox infections according to new research

Scientists have recently conducted a systematic review and meta-analysis to assess the types and prevalence of neurological and psychiatric symptoms associated with monkeypox virus infection in humans.

7 Jul 2022

Immune response triggered by COVID-19 damages the brain's blood vessels to cause neurological complications

A study from the National Institutes of Health describes the immune response triggered by COVID-19 infection that damages the brain's blood vessels and may lead to short- and long-term neurological symptoms.

5 Jul 2022

Impact of SARS-CoV-2 infection on menstrual cycle

Researchers systematically reviewed the impact of COVID-19 on the menstrual cycle.

4 Jul 2022

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

A new study examined electronic health records for approximately half the population of Denmark, looking for people with a diagnosis of COVID-19 or hospitalized with community-acquired pneumonia.

30 Jun 2022

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Antibiotic-resistant strains of Salmonella Typhi, the typhoid bacteria, have spread from South Asia to other countries nearly 200 times since 1990, new research suggests.

29 Jun 2022

Epigenome-wide DNA methylation patterns in convalescent COVID-19 subjects

Researchers investigated the epigenetic rewiring of odor perception in SARS-CoV-2-infected cells.

29 Jun 2022

Neural effects of COVID-19 on depressive symptoms

A new study identifies brain abnormalities in patients who recovered from COVID-19.

28 Jun 2022

Physicians prescribe less pain medication during nightshifts than during the day

Pain management is one of the biggest challenges of the modern healthcare system. Almost 60% of US adults report having experienced pain in the past three months and pain is one of the main reasons adults seek medical care.

27 Jun 2022

Innovative treatment reduces post-traumatic headache related disability, study finds

The first therapy to be developed specifically for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury (TBI).

27 Jun 2022

Night shift work is an important source of bias in pain management, study shows

Doctors who are sleep deprived have less empathy for patient pain and that perception affects their prescribing habits, according to a new international study from the University of Missouri School of Medicine and researchers in Israel.

27 Jun 2022

The prevalence of long-COVID in children and adolescents

A recent study published in the Scientific Reports journal assessed the incidence of long-coronavirus disease (COVID) among adolescents and children.

27 Jun 2022

Headache News and Research

Latest Headache News and Research

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

New Oxford study examines the effectiveness of pharmacological treatments for insomnia

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

COVID-19 risks may be heightened by history of Lyme disease

CDC posts investigation notice about multistate outbreak of Listeria infections

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

What is the monkeypox transmission risk in metropolitan areas?

Neuropsychiatric symptoms prevalent in over 50% of monkeypox infections according to new research

Immune response triggered by COVID-19 damages the brain's blood vessels to cause neurological complications

Impact of SARS-CoV-2 infection on menstrual cycle

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Epigenome-wide DNA methylation patterns in convalescent COVID-19 subjects

Neural effects of COVID-19 on depressive symptoms

Physicians prescribe less pain medication during nightshifts than during the day

Innovative treatment reduces post-traumatic headache related disability, study finds

Night shift work is an important source of bias in pain management, study shows

The prevalence of long-COVID in children and adolescents

Forensics and toxicology - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Headache News and Research

Latest Headache News and Research

Forensics and toxicology - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in